Literature DB >> 1262530

Isoproterenol sensitivity and total body clearance of propranolol in hypertensive patients.

G M London, M E Safar, Y A Weiss, P L Milliez.   

Abstract

The isoproterenol sensitivity (dose-response curve) and the total body clearance of propranolol were measured in 80 men including 15 normal subjects and 65 essential hypertensive patients (20 borderline and 45 permanent hypertensives). The critical dose of isoproterenol was found to be directly correlated to weight (P less than 0.01), age (P less than 0.001), and basal diastolic arterial pressure (P less than 0.001). A partial correlation coefficient study showed that the diastolic arterial pressure was of greater influence than weight and age. The total body clearance of propranolol was inversely related to the basal diastolic arterial pressure (P less than 0.0001) in hypertensive patients. The study provides evidence that the level of basal diastolic arterial pressure could influence the beta-receptor responsiveness and the beta-adrenergic blockade in hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1262530     DOI: 10.1002/j.1552-4604.1976.tb01514.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  8 in total

Review 1.  The assessment of beta-adrenoceptor blocking drugs in man.

Authors:  D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

Review 2.  Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy.

Authors:  P P Lamy
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

3.  Racial differences in drug response: isoproterenol effects on heart rate in healthy males.

Authors:  D R Rutledge; L Cardozo; J D Steinberg
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

Review 4.  Drug use in the elderly: a review of problems and special considerations.

Authors:  R E Vestal
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

5.  Studies on the autonomic nervous system in borderline hypertension.

Authors:  J W Henquet; M van Baak; M Schols; K H Rahn
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

7.  Alterations in isoprenaline sensitivity in patients with cirrhosis: evidence of abnormality of the sympathetic nervous activity.

Authors:  M J Ramond; E Comoy; D Lebrec
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

Review 8.  Hypertension in the elderly: age- and disease-related complications and therapeutic implications.

Authors:  E G Lakatta; J D Cohen; J L Fleg; E D Frohlich; A H Gradman
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.